Home >> ALL ISSUES >> 2022 Issues >> Put It on the Board

Put It on the Board

image_pdfCreate PDF

Aurobac will work to shift the strategy related to antibiotic treatment regimens to new effective and targeted modalities combined with rapid and actionable diagnostics.

The joint venture’s headquarters will be in Lyon, France, and the company will combine the expertise of life science company Evotec with BioMérieux’s expertise in infectious disease diagnostics and with Boehringer Ingelheim’s drug discovery and clinical development capabilities.

CellaVision launches workflow solution for low-volume hematology labs

CellaVision launched at the AACC meeting in July its Diff-Line by Cella-​Vision, a workflow solution for low-volume hematology laboratories.

Diff-Line by CellaVision consists of three instruments for smearing, staining, and analyzing peripheral blood smears: CellaVision DC-1 (launched in 2019, FDA cleared in 2020), RAL SmearBox, and RAL StainBox.

The DC-1 is a single-slide analyzer that automates and digitizes the analysis of peripheral blood smears. It has an automated microscope, a digital camera, and a computer system that uses artificial intelligence to locate, digitally capture, and preclassify cells from stained blood smears. The preclassified cells are presented on a computer screen for review and verification.

The RAL SmearBox produces peripheral blood smears. The automated instrument uses a patented consumable to produce smears directly from a closed whole sample tube. CellaVision introduced the RAL SmearBox at the AACC meeting.

The RAL StainBox is a semiautomated instrument that uses the bath method and guides the laboratory through a step-by-step staining process. It uses MCDh methanol-free stains to ensure high stain quality and reproducibility while reducing exposure to toxic chemicals.

Diff-Line was available on the European market beginning in July, and CellaVision says it will be rolled out in additional markets this year.

New add-on digital pathology codes

The AMA CPT editorial panel in July released 13 new digital pathology add-on codes for 2023. CPT codes 0751T–0763T will be used to report additional clinical staff work and service requirements associated with digitizing glass slides for primary diagnosis. The new category III codes are the result of work the CAP did with the AMA panel.

CAP TODAY
X